Select Publications

Journal articles

Calon M; Menon K; Carr A; Henry RG; Rae CD; Brew BJ; Cysique LA, 2020, 'Additive and Synergistic Cardiovascular Disease Risk Factors and HIV Disease Markers' Effects on White Matter Microstructure in Virally Suppressed HIV', Journal of Acquired Immune Deficiency Syndromes, 84, pp. 543 - 551, http://dx.doi.org/10.1097/QAI.0000000000002390

Howdle GC; Quidé Y; Kassem MS; Johnson K; Rae CD; Brew BJ; Cysique LA; Quide Y, 2020, 'Brain amyloid in virally suppressed HIV-associated neurocognitive disorder', Neurology Neuroimmunology and Neuroinflammation, 7, pp. e739, http://dx.doi.org/10.1212/NXI.0000000000000739

Neelamegam M; McStea M; Kukreja A; Malavade S; Omar SFS; Wong PL; Chong ML; Shaktivel R; Cysique L; Kamarulzaman A; Kamaruzzaman SB; Rajasuriar R, 2020, 'HIV-associated neurocognitive disorder (HAND) in people living with HIV in Malaysia: Results from the malaysian HIV and aging (MHIVA) study', International Journal of Infectious Diseases, 101, pp. 292 - 293, http://dx.doi.org/10.1016/j.ijid.2020.09.764

Cysique LA; Brew BJ, 2019, 'Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm', Journal of Neurovirology, 25, pp. 710 - 721, http://dx.doi.org/10.1007/s13365-018-0706-5

Cysique LA; Messinis L; Albert SM, 2019, 'Could excess body weight be good for cognitive health in chronic HIV infection?', Neurology, 93, pp. 95 - 96, http://dx.doi.org/10.1212/WNL.0000000000007769

Aung HL; Kootar S; Gates TM; Brew BJ; Cysique LA, 2019, 'How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection?', European Geriatric Medicine, 10, pp. 227 - 238, http://dx.doi.org/10.1007/s41999-019-00164-6

Cysique LA; Jugé L; Lennon MJ; Gates TM; Jones SP; Lovelace MD; Rae CD; Johnson TP; Nath A; Brew BJ, 2019, 'HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection', AIDS, 33, pp. 433 - 441, http://dx.doi.org/10.1097/QAD.0000000000002076

Cysique LA; Brew BJ, 2019, 'Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection', , 165, pp. 71 - 82, http://dx.doi.org/10.1016/B978-0-444-64012-3.00006-X

Cysique LA, 2019, 'Processing Emotional Information in Alzheimer's Disease: Effects on Memory Performance and Neurophysiological Correlates (vol 14, pg 104, 2002)', DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 48, pp. 220 - 220, http://dx.doi.org/10.1159/000503763

Nichols M; Gates T; Soares J; Moffat K; Rae C; Brew B; Cysique L, 2018, 'Brain atrophic signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection', AIDS, 33, pp. 55 - 66, http://dx.doi.org/10.1097/QAD.0000000000002042

Cysique LA, 2018, 'Chronic Human Immunodeficiency Virus Infection With and Without Comorbidities Appears to Converge Toward Early Pathological Brain Aging', Biological Psychiatry Cognitive Neuroscience and Neuroimaging, 3, pp. 820 - 821, http://dx.doi.org/10.1016/j.bpsc.2018.08.005

Mukherjee T; Sakthivel R; Fong HY; McStea M; Chong ML; Omar SF; Chin AV; Kamaruzzaman S; Kamarulzaman A; Rajasuriar R; Cysique LA, 2018, 'Utility of Using the Montreal Cognitive Assessment (MoCA) as a Screening Tool for HIV-Associated Neurocognitive Disorders (HAND) In Multi-Ethnic Malaysia', AIDS and Behavior, 22, pp. 3226 - 3233, http://dx.doi.org/10.1007/s10461-018-2073-x

Wright EJ; Grund B; Robertson KR; Cysique L; Brew BJ; Collins GL; Poehlman-Roediger M; Vjecha MJ; Penalva De Oliveira AC; Standridge B; Carey C; Avihingsanon A; Florence E; Lundgren JD; Arenas-Pinto A; Mueller NJ; Winston A; Nsubuga MS; Lal L; Price RW, 2018, 'No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts', AIDS, 32, pp. 985 - 997, http://dx.doi.org/10.1097/QAD.0000000000001778

Bundell C; Brunt SJ; Cysique LA; Brusch A; Brew BJ; Price P, 2018, 'The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy', Pathology, 50, pp. 313 - 316, http://dx.doi.org/10.1016/j.pathol.2017.10.017

Siefried KJ; Mao L; Cysique LA; Rule J; Giles ML; Smith DE; McMahon J; Read TR; Ooi C; Tee BK; Bloch M; De Wit J; Carr A, 2018, 'Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy', AIDS, 32, pp. 35 - 48, http://dx.doi.org/10.1097/QAD.0000000000001685

Cysique LA; Jugé L; Gates T; Tobia M; Moffat K; Brew BJ; Rae C, 2018, 'Covertly active and progressing neurochemical abnormalities in suppressed HIV infection', Neurology Neuroimmunology and Neuroinflammation, 5, pp. &na, http://dx.doi.org/10.1212/NXI.0000000000000430

Cysique LA; Becker JT, 2017, 'HIV-related cognitive decline despite viral suppression and complex confounds in American women', Neurology, 89, pp. 1540 - 1541, http://dx.doi.org/10.1212/WNL.0000000000004503

Saloner R; Cysique LA, 2017, 'HIV-Associated neurocognitive disorders: A global perspective', Journal of the International Neuropsychological Society, 23, pp. 860 - 869, http://dx.doi.org/10.1017/S1355617717001102

Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA, 2017, 'Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure', Journal of Clinical and Experimental Neuropsychology, 39, pp. 753 - 767, http://dx.doi.org/10.1080/13803395.2016.1263282

Brew BJ; Cysique L, 2017, 'Does HIV prematurely age the brain?', Lancet HIV, 4, pp. e380 - e381, http://dx.doi.org/10.1016/S2352-3018(17)30108-X

Cysique LA; Soares JR; Geng G; Scarpetta M; Moffat K; Green M; Brew BJ; Henry RG; Rae C, 2017, 'Erratum to: White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration (Journal of NeuroVirology, (2017), 23, 4, (539-547), 10.1007/s13365-017-0524-1)', Journal of Neurovirology, 23, pp. 548 - 549, http://dx.doi.org/10.1007/s13365-017-0542-z

Cysique LA; Soares JR; Geng G; Scarpetta M; Moffat K; Green M; Brew BJ; Henry RG; Rae C, 2017, 'White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration', Journal of Neurovirology, 23, pp. 539 - 547, http://dx.doi.org/10.1007/s13365-017-0524-1

Kamminga J; Lal L; Wright EJ; Bloch M; Brew BJ; Cysique LA, 2017, 'Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use', Current HIV AIDS Reports, 14, pp. 83 - 92, http://dx.doi.org/10.1007/s11904-017-0349-9

Gott C; Gates T; Dermody N; Brew BJ; Cysique LA, 2017, 'Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity', PLOS ONE, 12, http://dx.doi.org/10.1371/journal.pone.0171887

Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; De Wit J; Carr A, 2017, 'Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression', Plos One, 12, pp. e0174613, http://dx.doi.org/10.1371/journal.pone.0174613

Cysique LA; Gott C; Gates TM; Dermody N; Brew BJ, 2017, 'Cognitive Change Trajectories in Virally Suppressed HIV-Infected Individuals Indicate High Prevalence of Disease Activity', PLoS One, 12, pp. e0171887, http://dx.doi.org/10.1371/journal.pone.0171887

Tobia M; Jones S; Lovelace M; Rae C; Cysique L; Brew B, 2016, 'Reduced cellular energy as a potential marker of HIV brain latency related neuropathogenesis: a pilot study', JOURNAL OF NEUROVIROLOGY, 22, pp. S76 - S77, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394093700158&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bloch M; Kamminga J; Jayewardene A; Bailey M; Carberry A; Vincent T; Quan D; Maruff P; Brew B; Cysique LA, 2016, 'A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review', Clinical Infectious Diseases, 63, pp. 687 - 693, http://dx.doi.org/10.1093/cid/ciw399

Brunt SJ; Cysique LA; Lee S; Burrows S; Brew BJ; Price P, 2016, 'Short communication: Do cytomegalovirus antibody levels associate with age-related syndromes in HIV patients stable on antiretroviral therapy?', AIDS Research and Human Retroviruses, 32, pp. 567 - 572, http://dx.doi.org/10.1089/aid.2015.0328

Brouillette MJ; Yuen T; Fellows LK; Cysique LA; Heaton RK; Mayo NE, 2016, 'Identifying neurocognitive decline at 36 months among HIV-positive participants in the CHARTER cohort using group-based trajectory analysis', Plos One, 11, pp. e0155766, http://dx.doi.org/10.1371/journal.pone.0155766

Gates TM; Cysique LA; Siefried KJ; Chaganti J; Moffat KJ; Brew BJ, 2016, 'Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder', AIDS, 30, pp. 591 - 600, http://dx.doi.org/10.1097/QAD.0000000000000951

Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M, 2016, 'The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults', Journal of Neurovirology, 22, pp. 56 - 65, http://dx.doi.org/10.1007/s13365-015-0368-5

Mayo NE; Brouillette M-J; Fellows LK, 2016, 'Understanding and optimizing brain health in HIV now: protocol for a longitudinal cohort study with multiple randomized controlled trials', BMC NEUROLOGY, 16, http://dx.doi.org/10.1186/s12883-016-0527-1

Gates TM; Cysique LA, 2016, 'The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review', CNS Drugs, 30, pp. 53 - 69, http://dx.doi.org/10.1007/s40263-015-0302-7

Cysique LA, 2015, 'Advancing research in NeuroAIDS using collaboration and public data sharing', BMC Medical Genomics, 8, http://dx.doi.org/10.1186/s12920-015-0150-9

Lundgren JD; Babiker AG; Gordin F; Emery S; Grund B; Sharma S; Avihingsanon A; Cooper DA; Fätkenheuer G; Llibre JM; Molina JM; Munderi P; Schechter M; Wood R; Klingman KL; Collins S; Clifford Lane H; Phillips AN; Neaton JD; Kelleher A; Cysique L; Jacoby S, 2015, 'Initiation of antiretroviral therapy in early asymptomatic HIV infection', New England Journal of Medicine, 373, pp. 795 - 807, http://dx.doi.org/10.1056/NEJMoa1506816

Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M, 2015, 'The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults', Journal of NeuroVirology, http://dx.doi.org/10.1007/s13365-015-0368-5

Brew BJ; Robertson K; Wright EJ; Churchill M; Crowe SM; Cysique LA; Deeks S; Garcia JV; Gelman B; Gray LR; Johnson T; Joseph J; Margolis DM; Mankowski JL; Spencer B, 2015, 'HIV eradication symposium: will the brain be left behind?', Journal of Neurovirology, 21, pp. 322 - 334, http://dx.doi.org/10.1007/s13365-015-0322-6

Cysique LA; Hey-Cunningham WJ; Dermody N; Chan P; Brew BJ; Koelsch KK, 2015, 'Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition', Plos One, 10, pp. e0120488, http://dx.doi.org/10.1371/journal.pone.0120488

Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CSN; Davies NNWS; Price P; Brew BJ, 2015, 'APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - A cross-sectional observational study', BMC Neurology, 15, pp. 51, http://dx.doi.org/10.1186/s12883-015-0298-0

Cysique LA, 2015, 'Editorial commentary: Should longitudinal multisite studies become the new standard for investigating neurocognitive functions in HIV infection?', Clinical Infectious Diseases, 60, pp. 481 - 482, http://dx.doi.org/10.1093/cid/ciu863

Cysique LA; Gandevia SC, 2015, 'HIV infection and obstructive sleep apnea: Why epidemiological data are needed', Journal of Applied Physiology, 118, pp. 248 - 249, http://dx.doi.org/10.1152/japplphysiol.00989.2014

Cysique LA; Becker JT, 2015, 'Lessons to be learned from the largest study of cognition in American women with HIV disease', Neurology, 84, pp. 220 - 221, http://dx.doi.org/10.1212/WNL.0000000000001166

Wright EJ; Grund B; Cysique LA; Robertson KR; Brew BJ; Collins G; Shlay JC; Winston A; Read TRH; Price RW, 2015, 'Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial', HIV MEDICINE, 16, pp. 97 - 108, http://dx.doi.org/10.1111/hiv.12238

Sikkes S; Pera A; de Vries S; Maruff P; Cysique L; Bakardjian H; Dubois B; Scheltens P, 2015, 'O4‐10‐02: Cross‐cultural differences in instrumental activities of daily living (IADL): Translations and adaptations of the amsterdam iadl questionnaire', Alzheimer's & Dementia, 11, http://dx.doi.org/10.1016/j.jalz.2015.07.400

Cysique LA; Koelsch KK, 2014, 'Primary HIV infection alters brain neurochemistry, but does antiretroviral treatment help?', Neurology, 83, pp. 1588 - 1589, http://dx.doi.org/10.1212/WNL.0000000000000947

Dwyer R; Wenhui L; Cysique L; Brew BJ; Lal L; Bain P; Wesselingh S; Wright EJ, 2014, 'Symptoms of depression and rates of neurocognitive impairment in HIV positive patients in Beijing, China', Journal of Affective Disorders, 162, pp. 89 - 95, http://dx.doi.org/10.1016/j.jad.2014.03.038

Cysique LA; Cysique LA; Heaton RK; Kamminga J; Lane T; Gates T; Moore DM; Hubner E; Carr A; Brew BJ, 2014, 'HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research', Journal of NeuroVirology, 20, pp. 258 - 268, http://link.springer.com/article/10.1007/s13365-014-0242-x

Lu GM; Brew BJ; Siefried KJ; Draper B; Cysique LA, 2014, 'Is the HIV dementia scale a reliable tool for assessing HIV-relatedneurocognitive decline?', Journal of AIDS and Clinical Research, 5, http://dx.doi.org/10.4172/2155-6113.1000269

Cysique LA; Brew BJ, 2014, 'The effects of HIV and aging on brain functions: Proposing a research framework and update on last 3 years' findings', Current Opinion in HIV and AIDS, 9, pp. 355 - 364, http://dx.doi.org/10.1097/COH.0000000000000078


Back to profile page